Baishen Chen
Overview
Explore the profile of Baishen Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Peng J, Chen B, Shen Z, Deng H, Liu D, Xie X, et al.
Int J Clin Exp Pathol
. 2015 Dec;
8(9):11042-50.
PMID: 26617822
Galactocerebrosidase (GALC) is a lysosomal enzyme responsible for glycosphingolipids degradation byproducts of which are important for synthesis of apoptosis mediator ceramide. Reduced expression of GALC has been identified in human...
12.
Gan X, Chen B, Shen Z, Liu Y, Li H, Xie X, et al.
Int J Clin Exp Med
. 2014 Oct;
7(9):2530-40.
PMID: 25356106
Esophageal cancer is one of the most common cancers worldwide. Despite recent progress in the development of novel therapies, esophageal carcinoma remains an aggressive cancer associated with a poor prognosis....
13.
Chen B, Chen J, House M, Cullen K, Nephew K, Guo Z
Mol Cancer Res
. 2012 Jan;
10(3):305-15.
PMID: 22246235
Resistance to cisplatin-based chemotherapy is responsible for therapeutic failure of many common human cancers including cancer of head and neck (HNC). Mechanisms underlying cisplatin resistance remain unclear. In this study,...
14.
Chen B, Rao X, House M, Nephew K, Cullen K, Guo Z
Cancer Lett
. 2011 Jun;
309(1):37-45.
PMID: 21684681
Glutathione peroxidase 3 (GPx3), a plasma antioxidant enzyme, maintains genomic integrity by inactivating reactive oxygen species (ROS), known DNA-damaging agents and mediators of cancer chemotherapy response. In this study, we...